title: Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegeneration.
abstract: Transcriptional dysregulation as a result of sequestration of essential transcription factors into protein aggregates formed by polyglutamine (polyQ) expansions can lead to late-onset progressive neurodegeneration. DNA microarray analysis of Drosophila expressing polyQ in the compound eye over time revealed large numbers of transcriptional changes at the earliest stages of the disease including repression of the transient receptor potential calcium channels in a polyQ-induced cell death specific manner. While significant differences in expression profiles were found between the Drosophila compound eye and polyQ-sensitive neural cells, a number of possible key overlapping regulators were extracted. Among these, PDK1 was shown to act as a mediator for polyQ-toxicity, suggesting the involvement of the TOR pathway in polyQ-induced neurodegeneration.
authors.affiliation: Laboratory for Cell Recovery Mechanisms, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
authors.forename: B
authors.initials: B
authors.lastname: Nelson
authors.forename: S
authors.initials: S
authors.lastname: Nishimura
authors.forename: H
authors.initials: H
authors.lastname: Kanuka
authors.forename: E
authors.initials: E
authors.lastname: Kuranaga
authors.forename: M
authors.initials: M
authors.lastname: Inoue
authors.forename: G
authors.initials: G
authors.lastname: Hori
authors.forename: H
authors.initials: H
authors.lastname: Nakahara
authors.forename: M
authors.initials: M
authors.lastname: Miura
mesh_terms: D064413:3-Phosphoinositide-Dependent Protein Kinases; D000375:Aging / Q000235:genetics / Q000378:metabolism; D000818:Animals; D001483:Base Sequence; D002478:Cells, Cultured; D029721:Drosophila Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D004331:Drosophila melanogaster / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000502:physiology; D019636:Neurodegenerative Diseases / Q000235:genetics* / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism / Q000502:physiology; D020411:Oligonucleotide Array Sequence Analysis; D010455:Peptides / Q000235:genetics / Q000378:metabolism*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000502:physiology*; D010957:Plasmids / Q000235:genetics; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D019893:Ribosomal Protein S6 Kinases / Q000378:metabolism; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases; D014158:Transcription, Genetic / Q000502:physiology
chemical_list: D064413:3-Phosphoinositide-Dependent Protein Kinases; D029721:Drosophila Proteins; D010455:Peptides; D019869:Phosphatidylinositol 3-Kinases; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D019893:Ribosomal Protein S6 Kinases; D058570:TOR Serine-Threonine Kinases; C097188:polyglutamine; C416303:target of rapamycin protein, Drosophila